It is a pharma private limited company based in Wavanje, Maharashtra, India, established in 2016.
2016 | Wavanje, Maharashtra, India | ActiveEpitask Pharmaceuticals Private Limited, a active private limited company, was established on 08 June 2016 in Wavanje, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24200MH2016PTC282170. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Meher Mohd Afzal Shaikh (Director), Mohammed Afzal Mohammed Rafi Shaikh (Director), Ikramullah Hafizullah Choudhary (Director). Past directors included Mohammed Afzal Mohammed Rafi Shaikh. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at H. No. 645, Wavanje Nawada, Sec. Pnl-1,, Wavanje, Maharashtra, 410206.
U24200MH2016PTC282170
282170
08 June 2016
₹1.00 M
₹0.40 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Epitask Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meher Mohd Afzal Shaikh | Director | 20 Aug 2022 | Current |
| Mohammed Afzal Mohammed Rafi Shaikh | Director | 08 Jun 2016 | Current |
| Ikramullah Hafizullah Choudhary | Director | 08 Jun 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epitask Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 836.65% increase. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth dipped by a decrease of 0.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Epitask Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Epitask Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Epitask Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epitask Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Meher Mohd Afzal Shaikh was appointed as a Director was appointed as a Director on 20 Aug 2022 & has been associated with this company since 3 years 4 months . was documented.
Epitask Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.
Epitask Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was recorded as a recent event.
Progress on Mohammed Afzal Mohammed Rafi Shaikh was appointed as a Director was appointed as a Director on 08 Jun 2016 & has been associated with this company since 9 years 6 months . was documented.
Ikramullah Hafizullah Choudhary was appointed as a Director was appointed as a Director on 08 Jun 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
The activity Epitask Pharmaceuticals Private Limited was registered on 08 Jun 2016 with Roc Mumbai & aged 9 years 6 months as per MCA records. was completed.
The CIN of Epitask Pharmaceuticals Private Limited is U24200MH2016PTC282170.
Epitask Pharmaceuticals Private Limited is headquartered at H. No. 645, Wavanje Nawada, Sec. Pnl-1,, Wavanje, Maharashtra, 410206.
Epitask Pharmaceuticals Private Limited was incorporated on 08 June 2016.
The current directors of Epitask Pharmaceuticals Private Limited are
The primary industry of Epitask Pharmaceuticals Private Limited is Pharma.
Epitask Pharmaceuticals Private Limited is unlisted.
The authorized capital of Epitask Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Epitask Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX